This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Traditionally, Medical Affairs has focused on cross-functional collaboration with commercial and R&D teams, medical communication, evidence generation, and dissemination. They are no longer “just” educating and informing doctors but helping to accelerate medicalscience innovation. See resource here.
Emma Booth, Head of EU Medical Capabilities, Amgen. Victoria Ho, Director, MedicalScience Liason Excellence, Jazz. Michael Zaiac, Head, Medical Affairs, Oncology EU, Novartis. The post Pharma Customer Engagement Europe | April 20-22, 2021 | Virtual appeared first on Pharma Marketing Network. SAVE YOUR SEAT!
This year’s data summarizes Web of Science citations from 2021, including 35,000 publications (journals, books and conference proceedings), 2.7 million citable items and 145 million cited references indexed in the Web of Science Core Collection. The 2021 JCR contained over 25% more articles and citations than the prior year.
Kaitlin joined Novartis Canada in 2017 as a MedicalScience Liaison in Immunology, prior to becoming a Medical Advisor in the Immunology Franchise in 2021, where she was responsible for chronic urticaria, psoriasis, and food allergy. About Impetus Digital.
Hence, the Web of Science Researcher Profiles go beyond time-saving automation and integration to empower researchers to showcase their influence and impact through a combination of factors including peer review data, citation metrics and compelling visualizations.
8 Future potential Celltrion sees potential for the platform to be applicable to other biologics, according to SungHyun Kim, Head of the company’s MedicalScience Division. Top companies and drugs by sales in 2021. About the authors Talat Imran was appointed CEO of Rani Therapeutics in June 2021. References Urquhart L.
This engagement is continuing to remain high, with evolving requirements and preferences of healthcare practitioners (HCPs) in the ways they engage with pharma reps and medicalscience liaisons (MSLs) through virtual communications.
The ecosystem of biotech ventures peaked in 2021. However, the situation has tremendously changed since the market crash began in November 2021. The early-stage venture financing firm Canaan Partners focuses on game-changing innovations in information, digital technologies, and the medicalsciences. Canaan Partners.
Piliero predicted several major change points for MedicalScience Liaisons (MSLs), including: MSLs will engage a broader range of external stakeholders beyond traditional physicians, including nurses, physician assistants, patients, academics, payers and policymakers, and digital opinion leaders (DOLs).
More bleakly, according to estimates from the WHO and The Guardian /Kaiser Health News, by the spring of 2021, more than 100,000 healthcare workers globally had died from COVID-19, and more than 3,600 of those were in the United States.
That is in the same vicinity as the results seen with Boehringer Ingelheim’s rival SGLT2 inhibitor Jardiance (empagliflozin) in the EMPEROR-Preserved in July 2021 in heart failure preserved ejection fraction (HFpEF).
Mehrdad was an adjunct clinical faculty member in the Division of Medical Oncology at Stanford University after completing his fellowships in haematology and medical oncology at Stanford and prior to that completed his internal medicine residency at University of California-Irvine. 2021; 39(31):3441–52. 2021; 8(12):e879–90.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content